Small Pharma To Participate In November Investor And Healthcare Conferences
Small Pharma to participate in Jefferies Conference and CNS Summit.
Small Pharma Reports Fiscal Second Quarter 2023 Highlights
Second quarter 2023 highlights including last patient dosed.
Small Pharma Enters Into Automatic Share Purchase Plan
The ASPP has been approved by the TSX Venture Exchange.
Small Pharma Announces TSXV Approval of Normal Course Issuer Bid
The TSX Venture Exchange has accepted Small Pharma's application.
Small Pharma Reports Fiscal First Quarter 2023 Highlights
Progress continues with multiple trials expected to enter clinic later this year.
Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022
Small Pharma reports highlights for the fiscal year ended February 2022.
Small Pharma Shares Business Update Ahead of Annual Financial Results
Small Pharma shares business update ahead of annual financial results, including a new COO appointment.
Small Pharma Reports Fiscal Third Quarter 2021 Highlights
Learn about Small Pharma's key business and financial third quarter results.
Small Pharma reports second quarter highlights
Second quarter highlights include advances to ongoing trials and fast-track innovation by MHRA.
Small Pharma to restate financial statements to reflect IFRS fair value of convertible notes and share options
Small Pharma to restate financial statements to reflect IFRS fair value.